STAT

Cancer is ‘natural.’ The best treatments for it aren’t

It's easy to believe that something that is "all natural" is intrinsically good. That doesn't apply to cancer treatments.
Scanning electron micrograph of a three-day old cluster of breast cancer cells.

In the early years of my career as an oncologist, I’m learning that you really remember the patients you can’t save. Those with essentially curable cancers who refused the right treatment stand out the most.

One of those is a patient I’ll call Ruth. She was only 30 when she was diagnosed with breast cancer, as I learned later from her medical history. It was localized to her left breast and contained within the relatively small tumor; there were no signs it had spread to other parts of her body. With the right treatment, Ruth had about a 75 percent chance of

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About MDMA For PTSD, A CRISPR Treatment For Blindness, And More
An FDA advisory panel will deliberate on June 4 whether to recommend approval for the first MDMA-assisted therapy for post-traumatic stress disorder.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About MorphoSys Drug Risks, An AstraZeneca Admission, And More
MorphoSys is dealing with a safety issue with pelabresib, the experimental treatment for myelofibrosis and centerpiece of its proposed $3 billion acquisition by Novartis.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

Related Books & Audiobooks